Taiwan Liposome Company, Ltd. American Depository Shares
TLC
TLC was delisted on the 28th of September, 2021.
5 hedge funds and large institutions have $191K invested in Taiwan Liposome Company, Ltd. American Depository Shares in 2020 Q3 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, 1 reducing their positions, and 2 closing their positions.
17% less funds holding
Funds holding: 6 → 5 (-1)
50% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 2
67% less capital invested
Capital invested by funds: $588K → $191K (-$397K)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
+$169K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$244K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$6K |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
-$1K |
TLC Hedge Fund Activity: Q3 2020 in Review
5 of the 4,957 institutional investors tracked by Wall St. Rank reported a position in Taiwan Liposome Company, Ltd. American Depository Shares (TLC) for Q3 2020, worth a combined $191K — down 67% from $588K a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of TLC and 1 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 0 added.
The largest buyer was Jane Street, opening a new position worth an estimated $169K. The largest seller was Millennium Management, cutting an estimated $244K.
- 5 institutional investors held Taiwan Liposome Company, Ltd. American Depository Shares (TLC) as of Q3 2020, down from 6 in Q2 2020.
- Funds reported $191K of Taiwan Liposome Company, Ltd. American Depository Shares stock for Q3 2020, down 67% quarter-over-quarter.
- 1 fund opened new Taiwan Liposome Company, Ltd. American Depository Shares positions in Q3 2020 and 2 closed out, a net change of -1 holder.
- The largest Taiwan Liposome Company, Ltd. American Depository Shares buyer in Q3 2020 was Jane Street, an estimated $169K added.
- The largest Taiwan Liposome Company, Ltd. American Depository Shares seller in Q3 2020 was Millennium Management, an estimated $244K sold.
Based on aggregated 13F filings for Q3 2020.